Thyroid Disorders in the Context of the COVID-19 Pandemic - Takeaways - MDSpire

Thyroid Disorders in the Context of the COVID-19 Pandemic

  • By

  • Majd Irsheid

  • Nitzan Burrack

  • Merav Fraenkel

  • Eli Hershkovitz

  • Uri Yoel

  • April 22, 2026

  • 0 min

Share

  • 1

    The COVID-19 pandemic significantly increased the incidence of Hashimoto’s Thyroiditis by 30% compared to the pre-pandemic period.

  • 2

    Graves’ Disease showed a non-significant upward trend in incidence during the pandemic, suggesting a possible increase.

  • 3

    Subacute Thyroiditis incidence decreased significantly by 54% during the pandemic, contrasting with trends observed in other thyroid disorders.

  • 4

    The study utilized a population-based retrospective cohort design, analyzing data from Clalit Health Services in Israel.

  • 5

    Findings indicate heterogeneous impacts of COVID-19 on different thyroid disorders, highlighting the need for further research.

Original Source(s)

Thyroid Disorders in the Context of the COVID-19 Pandemic

  • by Majd Irsheid, Nitzan Burrack, Merav Fraenkel, Eli Hershkovitz, Uri Yoel

  • April 22, 2026

Related Content

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis

Sociodemographic Factors Influencing eHealth Access in Spain: Addressing the Digital Divide

Association between hypothyroidism, levothyroxine replacement and kidney function outcomes: a systematic review and meta-analysis